DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20160980

ApoB/ApoA-1 ratio and nitric oxide levels in pregnancy induced hypertensive women

Visala Sree Jammalamadaga, Philips Abraham, P. Sivaprasad

Abstract


Background: Pregnancy induced hypertension is considered as the major cause of maternal and perinatal mortality. Even though occurrence of PIH is due to abnormal placentation, endothelial dysfunction plays a pivotal role in the genesis of the multisystem disorder that develops in pre eclampsia and eclampsia. Various studies have proved that hyperlipidemia is one of the major causes of endothelial dysfunction. Since ApoB/apoA-I ratio is a dyslipidemic indicator, the study was designed to determine ApoB/ApoA-I in PIH women and to analyse whether this ratio can be correlated with ED in PIH women.

Methods: A cross-sectional analytical study involved normotensive, preeclamptic and eclamptic pregnant women with hundred subjects in each group. They were investigated for serum lipid profile, ApoA, ApoB, NO, MDA, FRAP in the 3rd trimester of pregnancy.

Results: The SBP & DBP were significantly high between 3 groups. The mean plasma TC, TGL, VLDL, LDL, MDA, ApoB levels, ApoB/ApoA-I were significantly high & HDL, ApoA-I, NO, FRAP levels were significantly low between 3 groups. The ApoB/ApoA-I was positively correlated with TC, TGL, VLDL, LDL, malondialdehyde and negatively correlated with HDL, FRAP & NO.

Conclusions: Our results indicate that women with PE & E exhibit markedly elevated concentrations of TGL-rich lipoproteins. The negative correlation between ApoB/ApoA-I with NO indicates that the hyperlipidemia is directly related with severity of ED in PIH. So, careful monitoring of ApoB/ApoA-I along with NO might be helpful to predict the onset and progression of the disease.


Keywords


Pregnancy induced hypertension, ApoB/ApoA-I ratio, Nitric oxide

Full Text:

PDF

References


Maas AHEM, van’t Hof AWJ, de Boer MJ. Cardiovascular risk in women after metabolic complications in pregnancy. Netherlands Heart J. 2007;15,12.

Parmar MT, Solanki HM, Gosalia VV. Study of risk factors of perinatal death in pregnancy induced hypertension. National J Comm Med. 2012;3(4):703-7.

Saxena S, Srivastava PC, Thimmaraju KV, Mallick AK, Dalmia K, Das B. Socio-demographic profile of pregnancy induced hypertension in a tertiary care centre. Sch J App Med Sci. 2014;2(6D):3081-6.

Bell MJ, BSN RN. A historical overview of preeclampsia-eclampsia. J Obstet Gynecol Neonatal Nurs. 2010;39(5):510-8.

Packer CS. Biochemical markers and physiological parameters as indices for identifying patients at risk of developing pre-eclampsia. J Hypertension. 2005;23:45-6.

Spracklen CN, Smith CJ, Saftlas AF, Robinson JG, Ryckman KK. Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis. Am J Epidemiol. 2014;180(4):346-58.

Jose de LV, de Andrade CR, Ruschi GE, Sass N. Serum lipid levels in pregnancies complicated by preeclampsia. Sao Paulo Med J. 2011;129(2):73-6.

Musa AH, Mairiga AG, Jimeta AA, Ahmed A, Daja A. Lipid profile pattern of pre-eclamptic and eclamptic patients attending University of Maiduguri Teaching Hospital. Gynecol Obstet (Sunnyvale). 2014;4:217.

Miles B. Review of Lipoproteins. 2003. Available from https://www.tamu.edu/faculty/bmiles/lectures/Lipid%20Transport.pdf. Accessed on 10 March, 2016.

Visser ME, Kastelein JJP, Stroes ES. Apolipoprotein B synthesis inhibition: results from clinical trials. Curr Opin Lipidol. 2010;21:319-23.

Walldius G. The apoB/apoA-I ratio is a strong predictor of cardiovascular risk. Lipoproteins-role in health and diseases. Doi: 10.5772/47869.

de Haro MJ, Martnez-Aguilar E, Florez A, Varela C, Bleda S, Francisco A. Nitric oxide: link between endothelial dysfunction and inflammation in patients with peripheral arterial disease of the lower limbs. Interactive Cardio Vascular and Thoracic Surgery. 2009;9:107-12.

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Bethesda, Maryland.

Schwartz RB. Preeclampsia-Eclampsia: Clinical and Neuroradiographic correlates and Insights into the Pathogenesis of Hypertensive Encephalopathy. Radiology. 2000;217:371-6.

Fetal and perinatal outcomes in maternal hypertension. Vaillancourt, Cathy, and Julie Lafond, eds. Pregnancy Disorders and Perinatal Outcomes. Bentham Science Publishers. 2012.

Johnson AC. Mechanisms of seizure during pregnancy and preeclampsia. University of Vermont Scholar Works @ UVM. Graduate College Dissertations and Theses. 2015.

Sena CM, Pereira AM, Seiça R. Endothelial dysfunction- A major mediator of diabetic vascular disease. Biochimica et Biophysica Acta. 2013;1832:2216-31.

Saha T. Role of nitric oxide, angiogenic growth factors and biochemical analysis in preeclampsia. Indian J Biochem Biophysics. 2013;50:462-6.

Peramaiyan R, Thamaraiselvan R, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G et al. The Vascular Endothelium and Human Diseases. Int J Biol Sci. 2013;9(10):1057-69.

Ansar S, Koska J, Reaven PD. Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins. Cardiovascular Diabetology. 2011;10:61.

Ekambaram P, Munuswamy U. Lipid profile alterations and oxidative stress in patients with preeclampsia: role of black tea extract on disease management. Turk J Med Sci. 2011;41(5):761-8.

Pedro EMS, Leticia SO, Del Toro IC. Dyslipidemia in preeclampsia syndrome. Cor Salud. 2013;5(2):221-5.

Pradnya P, Tilak M. Study of lipid profile in pre-eclampsia. Indian J Basic & Appl Med Res. 2012;2(5):405-9.

Kaloti AS, Kaur C, Goel RK, Jha S. Study of lipid profile trends in women of pregnancy induced hypertension cases in a rural setup. J Evol Med Dental Sci. 2013;2(13):2024-31.

Ekhator CN, Ebomoyi MI. Blood glucose and serum lipid profiles during pregnancy. African J Diabet Med. 2012;20(1):16.

Philip S, Philips A, Sheriff DS. Apo B/Apo A-I ratio a better predictor of coronary artery disease in patients with or without type ii diabetes mellitus. Intern J Appl Biol Pharmaceutic Technol. 2011;2(3):153-8.

Wang J. Is an atherogenic lipoprotein profile in the fetus a prerequisite for placental vascular disease? British J Obstetr Gynaecol. 2000;107:508-13.

Community laboratory guide lines. Ontario association of medical laboratories. Revised. 2013.

Barbato JE. Nitric oxide and arterial disease. J Vascular Surg. 2004;40(1):187-93.

Adetunji OA, Dolapo PO. Comparison of lipid peroxidation and anti-oxidant activities in pre-eclamptic & normal pregnancies in Nigerian Population. Intern J Clin Med. 2013;4:239-43.

Sowndramalingam S, Yi X, Tatsuya S, Davidge ST. Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia role for peroxynitrite. Hypertension. 2009;53:270-7.